RPO LLC’s Cardio Diagnostics CDIO Stock Holding History

RPO LLC’s Portfolio CDIO Stock Details CDIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,797	Closed	-$1.45M	–	158
2022 Q3	$1.45M	Buy	+4,797	New	+$1.44M	0.35%	83

Other funds holding CDIO

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

ASM

ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

CSC

Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RPO LLC's CDIO Position: Q4 2022 in Review

RPO LLC sold out of Cardio Diagnostics (CDIO) in Q4 2022, closing a stake of 4,797 shares — an estimated $1.45M sold.

RPO LLC first reported a position in CDIO in Q3 2022 and held it in 1 quarter. The position peaked at $1.45M in Q3 2022. 11 funds tracked by Wall St. Rank hold CDIO as of Q4 2022.

RPO LLC reported no remaining Cardio Diagnostics position as of Q4 2022 after selling out during the quarter.
RPO LLC sold 4,797 Cardio Diagnostics shares in Q4 2022, an estimated $1.45M.
RPO LLC first reported a position in Cardio Diagnostics in Q3 2022 and held it in 1 quarter.
RPO LLC's Cardio Diagnostics position peaked at $1.45M in Q3 2022.
11 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q4 2022.

Based on RPO LLC's 13F filing for Q4 2022, filed 10 Feb 2023.